Toku Eyes creates diagnostic and screening tools to eliminate doctors' preventable health and vision deterioration.
Toku Eyes has raised $2.5M in total funding. The most recent round was Grant. The last funding was announced in September 2024.
Toku Eyes's investors include Icehouse Ventures, Callaghan Innovation, National Vision, Outset Ventures, Topcon Healthcare.
Toku Eyes is headquartered in Auckland, New Zealand.
Toku Eyes creates diagnostic and screening tools to eliminate doctors' preventable health and vision deterioration.
Toku Eyes is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Toku Eyes — Funding & Investors." VCBacked, September 30, 2024, https://www.vcbacked.co/company/toku-eyes. Accessed September 5, 2026.
VCBacked. (2024). Toku Eyes — Funding & Investors. Retrieved September 5, 2026, from https://www.vcbacked.co/company/toku-eyes
{{cite web |title=Toku Eyes — Funding & Investors |url=https://www.vcbacked.co/company/toku-eyes |website=VCBacked |access-date=September 5, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated